Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS

Neurology

Volumn 57, Issue 1, 2001, Pages 62-68

  Mancardi, G L ^a   Saccardi, R ^e   Filippi, M ^g   Gualandi, F ^b   Murialdo, A ^a   Inglese, M ^g   Marrosu, M G ^h   Meucci, G ⁱ   Massacesi, L ^f   Lugaresi, A ^j   Pagliai, F ^e   Sormani, M P ^c   Sardanelli, F ^d   Marmont, A ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b Neurology San Martino's Hospital   (Italy)

^c National Cancer Institute   (Italy)

^d Dermatology and Aesthetic Laser   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h UNIVERSITY OF CAGLIARI   (Italy)

ⁱ UNIVERSITY OF PISA   (Italy)

^j UNIVERSITY OF CHIETI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GADOLINIUM; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADULT; ALLOGRAFT; ARTICLE; AUTOIMMUNITY; AUTOTRANSPLANTATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEMYELINATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; MALE; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; PRIORITY JOURNAL;

EID: 0035838312     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.1.62     Document Type: Article

References (30)

1. Multiple sclerosis
2. Stem cell transplantation in experimental models of autoimmune disease
3. New horizons in the treatment of autoimmune diseases: Immunoablation and stem cell transplantation
4. Hematopoietic stem cell transplantation for severe autoimmune disease: Know thyself
5. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: First results of a pilot study
6. Autologous stem cell transplantation in progressive multiple sclerosis. An interim analysis of efficacy
7. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation
8. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis
9. Autologous hematopoietic stem cell transplants for autoimmune disease - Feasibility and transplant-related mortality
10. Standardizzazione e taratura italiana di test neuropsicologici
11. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials
12. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis
13. Visual analysis of serial T2-weighted MRI in multiple sclerosis: Intra- and interobserver reproducibility
14. Immunoablation with stem cell rescue: A possible cure for systemic lupus erythematosus?
15. Treatment of severe systemic lupus erythematosus with high dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study
16. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation
17. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor
18. Bone marrow transplantation in multiple sclerosis
19. Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24 month clinical and MRI outcome
20. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomized multicentre study of active disease using MRI and clinical criteria
21. Mitoxantrone in progressive multiple sclerosis: A placebo controlled, randomized, observer blind phase III trial: Clinical results and three year follow up
22. Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis
23. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: Relationship to course, gender and age
24. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis
25. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology
26. Axonal damage in acute multiple sclerosis lesions
27. Axonal transection in the lesion of multiple sclerosis
28. The treatment of chronic progressive multiple sclerosis with cladribine
29. Cladribine and progressive MS. Clinical and MRI outcomes of a multicenter controlled trial
30. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia